FNPSX
Price
$36.68
Change
-$0.74 (-1.98%)
Updated
Nov 13 closing price
Net Assets
23.01M
RYVLX
Price
$706.18
Change
-$30.26 (-4.11%)
Updated
Nov 13 closing price
Net Assets
1.56B
Interact to see
Advertisement

FNPSX vs RYVLX

Header iconFNPSX vs RYVLX Comparison
Open Charts FNPSX vs RYVLXBanner chart's image
ProFunds Financials UltraSector Svc
Price$36.68
Change-$0.74 (-1.98%)
VolumeN/A
Net Assets23.01M
Rydex NASDAQ-100® 2x Strategy A
Price$706.18
Change-$30.26 (-4.11%)
VolumeN/A
Net Assets1.56B
FNPSX vs RYVLX Comparison Chart in %
View a ticker or compare two or three
VS
FNPSX vs. RYVLX commentary
Nov 15, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FNPSX is a StrongBuy and RYVLX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RYVLX has more cash in the bank: 1.56B vs. FNPSX (23M). FNPSX (0.00) and RYVLX (0.00) have matching dividends . FNPSX was incepted earlier than RYVLX: FNPSX (25 years) vs RYVLX (21 years). FNPSX (2.76) is less costly to investors than RYVLX (1.87). RYVLX is a more actively managed with annual turnover of: 383.00 vs. FNPSX (178.00). RYVLX has a lower initial minimum investment than FNPSX: RYVLX (2500) vs FNPSX (15000). RYVLX annual gain was more profitable for investors over the last year : 19.98 vs. FNPSX (2.89). RYVLX return over 5 years is better than : 126.59 vs. FNPSX (95.63).
FNPSXRYVLXFNPSX / RYVLX
Total Expense Ratio2.761.74159%
Annual Report Gross Expense Ratio2.761.87148%
Fund Existence25 years21 years-
Gain YTD9.95228.26335%
Front LoadN/A5%-
Min. Initial Investment150002500600%
Min. Initial Investment IRAN/AN/A-
Net Assets23M1.56B1%
Annual Yield % from dividends0.000.00-
Returns for 1 year2.8919.9814%
Returns for 3 years68.26221.4331%
Returns for 5 years95.63126.5976%
Returns for 10 years183.01781.2523%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MRK92.931.48
+1.62%
Merck & Co
PSEC2.78-0.03
-1.07%
Prospect Capital Corp
MREO1.78-0.06
-3.26%
Mereo BioPharma Group plc
WIMI2.98-0.14
-4.49%
WiMi Hologram Cloud Inc
RGC13.00-0.68
-4.97%
Regencell Bioscience Holdings Limited